Serum vitamins and heavy metals in blood and urine, and the correlations among them in parkinson's disease patients in China

Neuroepidemiology

Volumn 36, Issue 4, 2011, Pages 240-244

  Fukushima, Tetsuhito ^a   Tan, Xiaodong ^b   Luo, Yunwen ^c   Kanda, Hideyuki ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b WUHAN UNIVERSITY   (China)

^c Xiangfan No 1 Hospital   (China)

Author keywords

Blood and urine levels; Case control study; China; Heavy metals; Parkinson's disease; Vitamins

Indexed keywords

ALPHA TOCOPHEROL; COPPER; CYANOCOBALAMIN; IRON; MANGANESE; ZINC;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CHINA; CONTROLLED STUDY; FEMALE; HUMAN; IRON BLOOD LEVEL; IRON URINE LEVEL; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PATHOPHYSIOLOGY; URINALYSIS; ZINC BLOOD LEVEL; ZINC URINE LEVEL;

CASE-CONTROL STUDIES; CHINA; FEMALE; HUMANS; MALE; METALS, HEAVY; MIDDLE AGED; PARKINSON DISEASE; VITAMINS;

EID: 79958767370     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000328253     Document Type: Article

References (25)

1. Bowler RM, Koller W, Schulz PE: Parkinson-ism due to manganism in a welder: neurological and neuropsychological sequelae. Neurotoxicology 2006; 27:327-332.
2. Couper J: On the effects of black oxide of manganese when inhaled into the lungs. Br Ann Med Pharm 1837; 1:41-42.
3. Takeda A: Manganese action in brain function. Brain Res Brain Res Rev 2003; 41: 79-87. (Pubitemid 36044595)
4. 1-weighted MR images: the correlation with manganese poisoning. Rinsho Shinkeigaku 1996; 36:780-782. (Pubitemid 26391143)
5. Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Brown GG, Richardson RJ: Occupational exposures to metals as risk factors for Parkinson's disease. Neurology 1997; 48:650-658. (Pubitemid 27120101)
6. Powers KM, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD, Checkoway H: Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes. Neurology 2003; 60:1761-1766. (Pubitemid 36737070)
7. Fukushima T, Tan X, Luo Y, Kanda H: Relationship between blood levels of heavy metals and Parkinson's disease in China. Neuro-epidemiology 2010; 34: 18-2 4.
8. Gaetke LM, Chow CK: Copper toxicity, oxi-dative stress, and antioxidant nutrients. Tox-icolog y 2003; 18 9: 14 7-1 6 3. (Pubitemid 36725029)
9. Suarez-Moreira E, Yun J, Birch CS, Williams JH, McCaddon A, Brasch NE: Vitamin B(12) and redox homeostasis: cob(II)alamin reacts with superoxide at rates approaching super-oxide dismutase (SOD). J Am Chem Soc 2009; 131: 15078-15079.
10. Bourre JM: Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. 1. Micronutrients. J Nutr Health Aging 20 06; 10: 37 7-3 8 5. (Pubitemid 44845348)
11. Levin J, Bötzel K, Giese A, Vogeser M, Lo-renzl S: Elevated levels of methylmalonate and homocysteine in Parkinson's disease, progressive supranuclear palsy and amyo-trophic lateral sclerosis. Dement Geriatr Cogn Disord 2010; 29: 553-559.
12. Heidarian E, Amini M, Parham M, Aminor-roaya A: Effect of zinc supplementation on serum homocysteine in type 2 diabetic patients with microalbuminuria. Rev Diabet Stud 2009; 6:64-70.
13. Daniel SE, Lees AJ: Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl 1993; 39:165-172. (Pubitemid 23216938)
14. SRL, Inc. 2006-2008. http://www.srl.info/srlinfo/news/2006-08.htm (in Japanese; accessed January 25, 2011).
15. Mitsubishi Chemical Medience Corporation. 2007. http://data.medience.co. jp/com pendium/main.asp?field=01&m-class= 09&s-class=0023 (in Japanese; accessed January 25, 2011).
16. Central Bio Laboratory. 2009. http://www. s-cyuken.co.jp/images/clinical/ kensaannai 2009.pdf (in Japanese; accessed January 25, 2011).
17. Cabrera-Valdivia F, Jiménez-Jiménez FJ, Molina JA, Férnandez-Calle P, Vázquez A, Cañizares-Liébana F, Larumbe-Lobalde S, Ayuso-Peralta L, Rabasa M, Codoceo R: Peripheral iron metabolism in patients with Parkinson's disease. J Neurol Sci 1994; 125: 82-86. (Pubitemid 24240192)
18. Mergler D, Huel G, Bowler R, Iregren A, Bé-langer S, Baldwin M, Tardif R, Smargiassi A, Martin L: Nervous system dysfunction among workers with long-term exposure to manganese. Environ Res 1994; 64:151-180. (Pubitemid 24068378)
19. Bowler RM, Roels HA, Nakagawa S, Drezgic M, Dia mond E, Pa rk R, Kol ler W, Bowler R P, Mergler D, Bouchard M, Smith D, Gwiazda R, Doty RL: Dose-effect relationships be-tween manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders. Occup Environ Med 20 07; 64: 16 7-17 7. (Pubitemid 46579825)
20. Miyake Y, Fukushima W, Tanaka K, Sasaki S, Kiyohara C, Tsuboi Y, Yamada T, Oeda T, M ik i T, Kawa mur a N, Sa k ae N, Fu kuyama H, Hirota Y, Nagai M, Fukuoka Kinki Parkinson's Disease Study Group: Dietary intake of antioxidant vitamins and risk of Parkinson's disease: a case-control study in Japan. Eur J Neurol 2011; 18: 10 6-113.
21. Bostanci MO, Bas O, Bagirici F: Alpha-to-copherol decreases iron-induced hippocam-pal and nigral neuron loss. Cell Mol Neuro-biol 2010; 30: 389-394.
22. Zhang SM, Hernán MA, Chen H, Spiegel-man D, Willett WC, Ascherio A: Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk. Neurolog y 20 02; 59: 1161-1169. (Pubitemid 35192385)
23. Pasbakhsh P, Omidi N, Mehrannia K, Sob-hani AG, Ragerdi Kashani I, Abbasi M, Kord Valeshabad A: The protective effect of vitamin E on locus coeruleus in early model of Parkinson's disease in rat: immunoreactivity evidence. Iran Biomed J 2008; 12:217-222.
24. 12 related to oxidative stress and neu-rotoxicity in Parkinson's patients? CNS Neu-rol Disord Drug Targets 2008; 7:20-27. (Pubitemid 351516213)
25. 12 and riboflavin and risk of Parkinson's disease: a case-control study in Japan. Br J Nutr 2010; 104:757-764.